NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On August 24, 2026, Azenta issued a press release announcing the resignation of John Marotta from his roles as Chief Executive Officer and as a director of the Company.
On this news, Azenta’s stock price fell $4.52 per share, or 12.09%, to close at $32.88 per share on August 24, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Hsbc Holdings PLC grew its position in Credo Technology Group Holding Ltd. (NASDAQ:CRDO – Free Report) by 50.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,602 shares of the company’s stock after purchasing an additional 33,621 shares during the quarter. Hsbc Holdings PLC owned approximately 0.05% of Credo Technology Group worth $27,321,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Reflection Asset Management purchased a new position in Credo Technology Group in the fourth quarter valued at approximately $25,000. Acumen Wealth Advisors LLC purchased a new stake in shares of Credo Technology Group during the 4th quarter worth approximately $25,000. Orion Capital Management LLC acquired a new position in shares of Credo Technology Group in the 2nd quarter valued at $27,000. AlphaCentric Advisors LLC purchased a new position in shares of Credo Technology Group in the 1st quarter valued at $33,000. Finally, Van ECK Associates Corp acquired a new stake in Credo Technology Group during the 4th quarter worth $37,000. Institutional investors and hedge funds own 80.46% of the company’s stock.
Analyst Ratings Changes A number of equities research analysts recently weighed in on the stock. The Goldman Sachs Group reissued a “buy” rating and issued a $250.00 price target on shares of Credo Technology Group in a research report on Tuesday, June 2nd. Weiss Ratings cut Credo Technology Group from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday. Evercore set a $292.00 price target on Credo Technology Group in a research note on Wednesday, September 2nd. Bank of America cut their target price on shares of Credo Technology Group from $340.00 to $275.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. Finally, Stifel Nicolaus upped their target price on shares of Credo Technology Group from $250.00 to $350.00 and gave the company a “buy” rating in a report on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $267.39.
View Our Latest Stock Report on Credo Technology Group Credo Technology Group Trading Down 1.7% Shares of CRDO opened at $167.75 on Wednesday. The stock’s 50 day moving average is $226.71 and its two-hundred day moving average is $190.08. Credo Technology Group Holding Ltd. has a twelve month low of $86.49 and a twelve month high of $308.67. The firm has a market capitalization of $31.53 billion, a PE ratio of 59.70, a P/E/G ratio of 0.68 and a beta of 3.22.
Credo Technology Group (NASDAQ:CRDO – Get Free Report) last posted its quarterly earnings results on Tuesday, September 1st. The company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.17 by $0.03. Credo Technology Group had a return on equity of 28.77% and a net margin of 33.83%.The business had revenue of $479.00 million during the quarter, compared to analysts’ expectations of $473.30 million. During the same period last year, the firm earned $0.52 EPS. The company’s quarterly revenue was up 114.7% compared to the same quarter last year. On average, sell-side analysts predict that Credo Technology Group Holding Ltd. will post 5.02 EPS for the current year.
Insider Buying and Selling at Credo Technology Group In other Credo Technology Group news, COO Yat Lam sold 55,441 shares of the business’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $213.02, for a total transaction of $11,810,041.82. Following the sale, the chief operating officer directly owned 2,529,169 shares in the company, valued at approximately $538,763,580.38. The trade was a 2.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO Chi Cheng sold 27,473 shares of the stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $209.53, for a total transaction of $5,756,417.69. Following the completion of the transaction, the chief technology officer owned 5,772,397 shares of the company’s stock, valued at $1,209,490,343.41. This represents a 0.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 376,784 shares of company stock valued at $88,299,791. 9.06% of the stock is owned by company insiders.
(Free Report)
Credo Technology Group, Inc (NASDAQ: CRDO) is a fabless semiconductor company that develops high‑speed connectivity solutions for cloud, enterprise and telecommunications infrastructure. The company focuses on semiconductors and related IP that enable reliable, low‑latency movement of large volumes of data between servers, switches and optical modules in data centers and network equipment.
Credo’s product portfolio centers on high‑speed analog and mixed‑signal devices designed to preserve signal integrity and extend reach over copper and optical links.
See Also Five stocks we like better than Credo Technology Group Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding CRDO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credo Technology Group Holding Ltd. (NASDAQ:CRDO – Free Report).
Receive News & Ratings for Credo Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credo Technology Group and related companies with MarketBeat.com's FREE daily email newsletter.
California State Teachers Retirement System increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 55,955.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 64,781,849 shares of the biotechnology company’s stock after purchasing an additional 64,666,282 shares during the period. California State Teachers Retirement System owned approximately 79.74% of Axon Enterprise worth $36,317,352,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise during the fourth quarter worth $28,000. Keating Financial Advisory Services Inc. acquired a new stake in Axon Enterprise in the second quarter worth $31,000. AlphaCentric Advisors LLC bought a new stake in Axon Enterprise in the fourth quarter valued at $34,000. Darwin Wealth Management LLC bought a new stake in Axon Enterprise in the second quarter valued at $37,000. Finally, Washington Trust Advisors Inc. raised its holdings in shares of Axon Enterprise by 1,300.0% during the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after purchasing an additional 65 shares during the period. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Stock Performance Shares of AXON opened at $515.67 on Tuesday. The firm has a market cap of $41.89 billion, a PE ratio of 213.97, a PEG ratio of 10.06 and a beta of 1.40. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $792.16. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The stock’s fifty day moving average price is $569.57 and its two-hundred day moving average price is $487.23.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same quarter last year, the company earned $2.12 earnings per share. The company’s revenue was up 35.3% on a year-over-year basis. On average, equities research analysts forecast that Axon Enterprise, Inc will post 2.04 EPS for the current year. Insider Buying and Selling In related news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the sale, the insider directly owned 97,761 shares in the company, valued at $61,266,818.70. This trade represents a 8.95% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 56,380 shares of company stock valued at $32,582,366. Company insiders own 4.20% of the company’s stock.
Analyst Ratings Changes AXON has been the topic of several research reports. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. UBS Group upped their price target on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Argus raised their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, Barclays lifted their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $721.57.
Read Our Latest Stock Analysis on AXON
Axon Enterprise Profile (Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Recommended Stories Five stocks we like better than Axon Enterprise 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
Concurrent Investment Advisors LLC raised its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 200.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,889 shares of the biotechnology company’s stock after buying an additional 3,260 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Axon Enterprise were worth $2,741,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in AXON. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $28,000. Keating Financial Advisory Services Inc. acquired a new position in Axon Enterprise in the 2nd quarter worth $31,000. AlphaCentric Advisors LLC bought a new position in Axon Enterprise during the 4th quarter worth about $34,000. Darwin Wealth Management LLC bought a new position in Axon Enterprise during the 2nd quarter worth about $37,000. Finally, Strive Financial Group LLC bought a new position in Axon Enterprise during the 4th quarter worth about $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
AXON stock opened at $505.43 on Wednesday. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $792.16. The business’s 50 day simple moving average is $568.47 and its 200 day simple moving average is $487.76. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $41.06 billion, a PE ratio of 209.72, a PEG ratio of 10.06 and a beta of 1.40.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The business had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same quarter last year, the firm posted $2.12 EPS. The company’s quarterly revenue was up 35.3% on a year-over-year basis. As a group, research analysts anticipate that Axon Enterprise, Inc will post 2.04 EPS for the current year. Wall Street Analysts Forecast Growth A number of research firms recently weighed in on AXON. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, July 22nd. Barclays increased their price objective on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Morgan Stanley raised their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. UBS Group lifted their target price on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $721.57.
Get Our Latest Stock Report on AXON
Insider Activity In other news, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president directly owned 296,974 shares of the company’s stock, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 56,380 shares of company stock valued at $32,582,366 over the last ninety days. 4.20% of the stock is currently owned by company insiders.
Axon Enterprise Profile (Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Recommended Stories Five stocks we like better than Axon Enterprise Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
Selective to Present at the 2026 Keefe, Bruyette & Woods Insurance Conference Selective Insurance Group, Inc. (Nasdaq: SIGI) announced today that John J. Marchioni, Chairman, President and Chief Executive Officer, and Patrick S. Brennan, Executive Vice President, Chief Financial Officer, will present at the 2026 Keefe, Bruyette & Woods Insurance Conference on Wednesday, September 9, 2026 at 4:20 p.m. ET. Investors can listen live to Selective’s presentation or access a recording by visiting the Investors page of www.Selective.com through October 9, 2026.
About Selective Insurance Group, Inc.
Selective Insurance Group, Inc. (Nasdaq: SIGI) is a holding company for 10 property and casualty insurance companies rated "A+" (Superior) by AM Best. Through independent agents, the insurance companies offer standard insurance for commercial and personal risks and specialty insurance for commercial risks. Selective also offers flood insurance through the National Flood Insurance Program's Write Your Own Program. Selective's unique position as both a leading insurance group and employer of choice is widely recognized, with awards and honors including listing in Forbes Best Midsize Employers and certification for seven consecutive years as a Great Place to Work®.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908997585/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Hsbc Holdings PLC boosted its position in shares of Ingersoll Rand Inc. (NYSE:IR – Free Report) by 12.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 796,787 shares of the industrial products company’s stock after purchasing an additional 91,333 shares during the period. Hsbc Holdings PLC owned about 0.21% of Ingersoll Rand worth $65,397,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Bell Investment Advisors Inc acquired a new position in Ingersoll Rand in the second quarter worth $26,000. Deseret Mutual Benefit Administrators grew its holdings in Ingersoll Rand by 46.9% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 351 shares of the industrial products company’s stock worth $28,000 after acquiring an additional 112 shares during the last quarter. Hilton Head Capital Partners LLC acquired a new stake in Ingersoll Rand in the 4th quarter valued at about $29,000. Reflection Asset Management acquired a new stake in Ingersoll Rand in the 4th quarter valued at about $31,000. Finally, Arax Advisory Partners bought a new position in shares of Ingersoll Rand in the fourth quarter worth about $35,000. 95.27% of the stock is owned by institutional investors.
Insider Transactions at Ingersoll Rand In related news, Director Aurobind Satpathy bought 11,538 shares of Ingersoll Rand stock in a transaction on Monday, August 3rd. The shares were purchased at an average price of $86.68 per share, for a total transaction of $1,000,113.84. Following the completion of the acquisition, the director owned 11,538 shares in the company, valued at approximately $1,000,113.84. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.49% of the company’s stock.
Analyst Ratings Changes Several research firms have recently commented on IR. Morgan Stanley set a $87.00 price target on shares of Ingersoll Rand in a research note on Monday, August 10th. Wall Street Zen cut shares of Ingersoll Rand from a “buy” rating to a “hold” rating in a research report on Sunday, August 2nd. Weiss Ratings raised Ingersoll Rand from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, July 21st. Evercore set a $84.00 price objective on Ingersoll Rand in a research report on Monday, May 11th. Finally, Stifel Nicolaus raised Ingersoll Rand from a “hold” rating to a “buy” rating and set a $101.00 target price for the company in a research note on Monday, August 3rd. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Ingersoll Rand currently has an average rating of “Moderate Buy” and a consensus target price of $96.14. Check Out Our Latest Analysis on Ingersoll Rand
Ingersoll Rand Trading Down 0.0% Shares of NYSE IR opened at $76.34 on Tuesday. Ingersoll Rand Inc. has a fifty-two week low of $68.07 and a fifty-two week high of $100.96. The firm has a market capitalization of $29.62 billion, a P/E ratio of 31.42, a P/E/G ratio of 4.80 and a beta of 1.15. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.62 and a quick ratio of 1.15. The company’s 50 day simple moving average is $81.57 and its 200 day simple moving average is $80.87.
Ingersoll Rand (NYSE:IR – Get Free Report) last released its earnings results on Thursday, July 30th. The industrial products company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.03. Ingersoll Rand had a net margin of 12.08% and a return on equity of 12.90%. The firm had revenue of $2.05 billion during the quarter, compared to analyst estimates of $1.96 billion. During the same quarter in the previous year, the business earned $0.80 EPS. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. Ingersoll Rand has set its FY 2026 guidance at 3.570-3.570 EPS. On average, analysts predict that Ingersoll Rand Inc. will post 3.39 EPS for the current year.
Ingersoll Rand Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Thursday, August 13th were paid a $0.02 dividend. The ex-dividend date of this dividend was Thursday, August 13th. This represents a $0.08 annualized dividend and a yield of 0.1%. Ingersoll Rand’s dividend payout ratio is presently 3.29%.
About Ingersoll Rand (Free Report)
Ingersoll Rand is a diversified industrial company that designs, manufactures and services a wide range of equipment and technologies for commercial, industrial and OEM customers. Its product portfolio includes air compressors and compressed air systems, pneumatic and cordless power tools, material handling and lifting equipment, fluid transfer and pumping solutions, and associated aftermarket parts and service offerings. The company’s products support applications across manufacturing, construction, transportation, oil and gas, mining and general industrial markets.
Ingersoll Rand sells through a combination of direct sales, distributor networks and service channels, delivering both capital equipment and recurring aftermarket revenue from parts, maintenance and service contracts.
Featured Stories Five stocks we like better than Ingersoll Rand 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Ingersoll Rand Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingersoll Rand and related companies with MarketBeat.com's FREE daily email newsletter.
Axalta Coating Systems is leveraging digital color management and operational efficiency to compete on repair cost, not just paint pricing. AXTA's Q2 2026 results show margin expansion and deleveraging, but volume recovery remains muted and headline growth is aided by price/mix and acquisitions. The pending AkzoNobel merger offers $600M in targeted synergies, but value creation hinges on execution, integration, and sustaining customer productivity advantages.
Belden named Top 10 Enterprise-Wide ERGs and Councils; RISE ERG recognized as Top 3 ERGs and Councils for Organizational Impact
ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC), a leading global provider of complete connection solutions, today announced it has received two recognitions in the 2026 GEN IMPACT Awards from the Global ERG Network ® (GEN). The GEN IMPACT Awards recognize Employee Resource Groups (ERGs), Councils and Executive Sponsors that are making meaningful impact and delivering measurable organizational outcomes across industries.
Belden received the following recognition: • Top 10 Enterprise-Wide ERGs and Councils • Rising Professionals Network Employee Resource Group, RISE, recognized as Top 3 ERGs and Councils for Organizational Impact
Share Belden received the following recognition:
Top 10 Enterprise-Wide ERGs and Councils Rising Professionals Network Employee Resource Group, RISE, recognized as Top 3 ERGs and Councils for Organizational Impact “Being recognized among the Top 10 Enterprise-Wide ERGs and Councils—and seeing our RISE Employee Resource Group named a Top 3 ERG for Organizational Impact—is a meaningful reflection of our people and our culture,” said Leah Tate, Belden’s Chief People & Strategy Officer. “At Belden, when people feel they belong, they bring their best. Our ERGs are more than communities—they’re catalysts for learning, connection, leadership and engagement that create real impact across the organization and strengthen Belden for the long term.”
Recipients were selected from hundreds of submissions and evaluated on their ability to Innovate, Measure, Progress, Activate, Collaborate and Transform (IMPACT) — reflecting the strategic contributions ERGs and Councils make for individuals, organizations, and communities including strengthening retention and building talent pipelines.
“When employee groups are genuinely wired into the heart of a business, incredible things happen,” said Monica Brunache, Executive Officer of Organizational and Employee Strategy at Tapestry Partner Solutions, which powers GEN. “This year’s winners are growing future leaders, spotting what their people actually need, and keeping everyone grounded through tough times. The GEN IMPACT Awards are all about celebrating that real-world impact and the hard work behind it.”
Award recipients will be celebrated at the 2026 GEN Conference in Charlotte, NC, November 10–11.
About Belden
Belden Inc. delivers complete connection solutions that unlock untold possibilities for our customers, their customers and the world. We advance ideas and technologies that enable a safer, smarter and more prosperous future. Throughout our 120+ year history we have evolved as a company, but our purpose remains – making connections. By connecting people, information and ideas, we make it possible. We are headquartered in St. Louis and have manufacturing capabilities in North America, Europe, Asia and Africa. For more information, visit us at www.belden.com; follow us on Facebook, LinkedIn and X/Twitter.
Belden and the Belden logo, Hirschmann, Hirschmann IT and ProSoft Technology are trademarks or registered trademarks of Belden Inc. or its affiliated companies in the United States and other jurisdictions. Belden and other parties may also have trademark rights in other terms used herein.
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) and Amtech Systems (NASDAQ:ASYS – Get Free Report) are both technology companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.
Risk and Volatility Silicon Laboratories has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, Amtech Systems has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500.
Profitability This table compares Silicon Laboratories and Amtech Systems’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Silicon Laboratories -4.57% -0.66% -0.57% Amtech Systems 4.90% 6.33% 4.00% Analyst Ratings This is a summary of current recommendations for Silicon Laboratories and Amtech Systems, as reported by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silicon Laboratories 2 5 0 0 1.71 Amtech Systems 0 3 1 0 2.25 Silicon Laboratories currently has a consensus target price of $218.00, indicating a potential downside of 0.91%. Amtech Systems has a consensus target price of $22.00, indicating a potential upside of 42.03%. Given Amtech Systems’ stronger consensus rating and higher possible upside, analysts clearly believe Amtech Systems is more favorable than Silicon Laboratories.
Earnings & Valuation This table compares Silicon Laboratories and Amtech Systems”s revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Silicon Laboratories $855.89 million 8.58 -$64.91 million ($1.18) -186.44 Amtech Systems $79.36 million 3.42 -$30.33 million $0.26 59.58 Amtech Systems has lower revenue, but higher earnings than Silicon Laboratories. Silicon Laboratories is trading at a lower price-to-earnings ratio than Amtech Systems, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership 50.2% of Amtech Systems shares are owned by institutional investors. 1.6% of Silicon Laboratories shares are owned by company insiders. Comparatively, 26.9% of Amtech Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary Amtech Systems beats Silicon Laboratories on 12 of the 14 factors compared between the two stocks.
(Get Free Report)
Silicon Laboratories Inc., a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation. The company sells its products through its direct sales force, as well as through a network of independent sales representatives and distributors. Silicon Laboratories Inc. was founded in 1996 and is headquartered in Austin, Texas.
About Amtech Systems (Get Free Report)
Amtech Systems, Inc. manufactures and sells capital equipment and related consumables for use in fabricating silicon carbide (SiC), silicon power devices, analog and discrete devices, electronic assemblies, and light-emitting diodes (LEDs) worldwide. The company operates through Semiconductor and Material and Substrate segments. The Semiconductor segment designs, manufactures, sells, and services thermal processing equipment, including solder reflow ovens, horizontal diffusion furnaces, and custom high-temp belt furnaces for use by semiconductor, electronics, and electro/mechanical assembly manufacturers; and diffusion and reflow thermal systems, as well as wafer cleaning equipment and related services. The Material and Substrate segment manufactures and sells consumables and machinery for lapping and polishing of materials, such as silicon wafers for semiconductor products; sapphire substrates for LED lighting and mobile devices; silicon carbide wafers for LED and power device applications; various glass and silica components for 3D image transmission; quartz and ceramic components for telecommunications devices; and medical device components, and optical and photonics applications. It also offers substrate products comprising of double-sided wafer cleaning system, entegrity head tester, substrate carrier, substrate polishing templates, double-sided lapping and polishing machines, single-sided polisher, and substrate process chemicals. The company sells its products through sales personnel, as well as a network of independent sales representatives and distributors. Amtech Systems, Inc. was incorporated in 1981 and is headquartered in Tempe, Arizona.
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
LAKE FOREST, Ill.--(BUSINESS WIRE)--Packaging Corporation of America's (NYSE: PKG) Chief Executive Officer, Mark Kowlzan, will participate in a Fireside Chat at Jefferies 2026 Global Industrials Conference being held in New York on Thursday, September 10, 2026 at 8:10am Eastern Time. Following, Mr. Kowlzan and Executive Vice President and CFO, Kent Pflederer will participate in a Q&A session. Immediately afterwards, they will be hosting a series of 1 x 1 meetings. For those interested in li.
Workers at Yancoal Australia's (YAL.AX) Premier coal mine voted in favour of a strike, seeking higher pay and greater certainty over entitlements and future earnings, the Mining and Energy Union (MEU) said on Wednesday.
Here are the details:
More than 90% of MEU members supported every proposed action, including stoppages longer than 12 hours, but did not say when they would go on strike.
The strike is also backed by members of the Australian Manufacturing Workers’ Union, with 93% voting in favour.
The Premier coal mine, which supplies coal to power generators in Western Australia, is expected to close around the end of the decade amid Western Australia's transition away from government-owned coal-fired power generation by 2030.
The union explained that the current agreement includes six possible roster arrangements, some of which could affect redundancy calculations if implemented.
Yancoal Australia did not immediately respond to a Reuters request for comment. Its majority shareholder is Chinese state-backed miner Yankuang Energy (600188.SS).
Australian miners are facing rising cases of industrial action, amid inflation and changes to workplace laws under the Labor government.
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of unusually large options trading on Tuesday. Traders bought 2,316 call options on the company. This represents an increase of approximately 139% compared to the typical daily volume of 968 call options.
Beam Therapeutics Trading Down 9.5% Shares of Beam Therapeutics stock opened at $26.83 on Wednesday. The firm’s 50 day moving average is $29.09 and its 200 day moving average is $28.96. The firm has a market capitalization of $2.77 billion, a PE ratio of -31.20 and a beta of 2.22. Beam Therapeutics has a 1 year low of $19.35 and a 1 year high of $38.26. The company has a current ratio of 14.57, a quick ratio of 14.57 and a debt-to-equity ratio of 0.09.
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported ($1.18) EPS for the quarter, missing the consensus estimate of ($1.11) by ($0.07). The company had revenue of $0.49 million during the quarter, compared to the consensus estimate of $16.37 million. Beam Therapeutics had a negative net margin of 54.75% and a negative return on equity of 30.71%. Beam Therapeutics’s revenue for the quarter was down 94.2% on a year-over-year basis. During the same period in the previous year, the company earned ($1.00) EPS. Equities research analysts forecast that Beam Therapeutics will post -4.49 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades Several research firms have commented on BEAM. HC Wainwright reissued a “buy” rating and issued a $80.00 target price on shares of Beam Therapeutics in a report on Tuesday, August 25th. Wall Street Zen upgraded shares of Beam Therapeutics from a “strong sell” rating to a “sell” rating in a research report on Saturday. Bank of America restated a “buy” rating and set a $47.00 price objective on shares of Beam Therapeutics in a research report on Wednesday, July 8th. Sanford C. Bernstein cut their target price on Beam Therapeutics from $40.00 to $39.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Finally, Tudor Pickering set a $39.00 target price on Beam Therapeutics in a report on Wednesday, May 13th. Ten equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $49.00. View Our Latest Research Report on BEAM
Insiders Place Their Bets In other news, insider Amy Simon sold 16,667 shares of the stock in a transaction on Monday, July 27th. The stock was sold at an average price of $25.74, for a total transaction of $429,008.58. Following the sale, the insider directly owned 85,696 shares of the company’s stock, valued at approximately $2,205,815.04. This represents a 16.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Fmr Llc sold 251,488 shares of the stock in a transaction on Friday, June 26th. The stock was sold at an average price of $35.26, for a total value of $8,867,466.88. Following the sale, the insider directly owned 854,583 shares in the company, valued at approximately $30,132,596.58. This trade represents a 22.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 301,527 shares of company stock worth $10,468,500. Corporate insiders own 3.80% of the company’s stock.
Institutional Investors Weigh In On Beam Therapeutics Hedge funds have recently modified their holdings of the company. ARK Investment Management LLC increased its holdings in Beam Therapeutics by 12.9% in the 4th quarter. ARK Investment Management LLC now owns 12,467,189 shares of the company’s stock worth $345,590,000 after purchasing an additional 1,428,355 shares in the last quarter. BlackRock Inc. bought a new position in Beam Therapeutics in the 2nd quarter valued at approximately $308,796,000. State Street Corp raised its holdings in Beam Therapeutics by 30.4% in the 4th quarter. State Street Corp now owns 5,228,529 shares of the company’s stock valued at $144,935,000 after buying an additional 1,219,871 shares during the last quarter. ARCH Venture Management LLC bought a new stake in Beam Therapeutics during the 2nd quarter worth approximately $155,771,929. Finally, California State Teachers Retirement System increased its position in Beam Therapeutics by 3,228.9% in the 2nd quarter. California State Teachers Retirement System now owns 3,586,612 shares of the company’s stock valued at $123,093,000 after acquiring an additional 3,478,871 shares during the period. Institutional investors and hedge funds own 99.68% of the company’s stock.
(Get Free Report)
Beam Therapeutics, Inc (NASDAQ: BEAM) is a biotechnology company dedicated to developing precision genetic medicines through its pioneering base editing platform. Headquartered in Cambridge, Massachusetts, with additional research facilities in Philadelphia, the company focuses on engineering molecular editors capable of making precise single-nucleotide changes in DNA. By harnessing its proprietary base editing technology, Beam aims to correct or disrupt disease-causing genetic variants at their source, offering the potential for novel therapies in areas with significant unmet medical need.
Founded in 2017 as a spin-out from Harvard University and the Broad and Whitehead Institutes, Beam was co-founded by leading academic researcher David R.
Further Reading Five stocks we like better than Beam Therapeutics Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Receive News & Ratings for Beam Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beam Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
FSK remains a hold, despite a recent 14% price jump post-Q2 2026 earnings. FSK's NAV dropped over $0.50 per share in one quarter, driven by realized and unrealized portfolio losses. Dividend coverage is narrow and currently aided by a temporary incentive fee waiver, which expires after three more quarters.
HB Wealth Management LLC boosted its holdings in shares of Arthur J. Gallagher & Co. (NYSE:AJG – Free Report) by 25.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,157 shares of the financial services provider’s stock after buying an additional 2,465 shares during the quarter. HB Wealth Management LLC’s holdings in Arthur J. Gallagher & Co. were worth $2,791,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the business. Kemnay Advisory Services Inc. acquired a new stake in shares of Arthur J. Gallagher & Co. in the fourth quarter worth $26,000. Rakuten Securities Inc. lifted its position in Arthur J. Gallagher & Co. by 650.0% during the second quarter. Rakuten Securities Inc. now owns 105 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 91 shares during the period. Axiom Investment Management LLC purchased a new stake in Arthur J. Gallagher & Co. in the first quarter valued at $28,000. MV Capital Management Inc. purchased a new stake in Arthur J. Gallagher & Co. in the fourth quarter valued at $34,000. Finally, Cassaday & Co Wealth Management LLC acquired a new stake in Arthur J. Gallagher & Co. during the 1st quarter worth about $29,000. 85.53% of the stock is owned by hedge funds and other institutional investors.
Insider Activity In related news, VP Christopher E. Mead sold 3,500 shares of Arthur J. Gallagher & Co. stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $257.02, for a total value of $899,570.00. Following the sale, the vice president owned 22,223 shares of the company’s stock, valued at approximately $5,711,755.46. This trade represents a 13.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Scott R. Hudson sold 12,000 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $264.13, for a total transaction of $3,169,560.00. Following the completion of the sale, the vice president directly owned 90,262 shares of the company’s stock, valued at approximately $23,840,902.06. The trade was a 11.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 27,500 shares of company stock worth $7,310,090 over the last three months. 1.40% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes A number of equities analysts have weighed in on AJG shares. Argus lifted their price objective on Arthur J. Gallagher & Co. from $267.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, August 17th. Mizuho raised their target price on Arthur J. Gallagher & Co. from $287.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Morgan Stanley lifted their price target on Arthur J. Gallagher & Co. from $270.00 to $290.00 and gave the company an “overweight” rating in a research report on Wednesday, August 19th. Citigroup boosted their price target on Arthur J. Gallagher & Co. from $250.00 to $285.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Finally, Royal Bank Of Canada upped their price objective on Arthur J. Gallagher & Co. from $300.00 to $310.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. Fourteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Arthur J. Gallagher & Co. presently has a consensus rating of “Moderate Buy” and a consensus target price of $290.28. Get Our Latest Analysis on AJG
Arthur J. Gallagher & Co. Trading Down 4.3% Shares of Arthur J. Gallagher & Co. stock opened at $251.47 on Wednesday. The firm has a 50-day simple moving average of $255.31 and a two-hundred day simple moving average of $228.39. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.05 and a current ratio of 1.05. Arthur J. Gallagher & Co. has a fifty-two week low of $190.75 and a fifty-two week high of $313.55. The company has a market cap of $64.45 billion, a P/E ratio of 41.70, a price-to-earnings-growth ratio of 1.59 and a beta of 0.50.
Arthur J. Gallagher & Co. (NYSE:AJG – Get Free Report) last posted its earnings results on Thursday, July 30th. The financial services provider reported $2.84 EPS for the quarter, beating analysts’ consensus estimates of $2.81 by $0.03. Arthur J. Gallagher & Co. had a return on equity of 13.28% and a net margin of 9.96%.The firm had revenue of $3.95 billion for the quarter, compared to analysts’ expectations of $4.01 billion. During the same period last year, the firm earned $2.33 EPS. The company’s quarterly revenue was up 24.3% on a year-over-year basis. As a group, equities analysts predict that Arthur J. Gallagher & Co. will post 13.28 earnings per share for the current fiscal year.
Arthur J. Gallagher & Co. Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Tuesday, September 8th will be issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, September 8th. Arthur J. Gallagher & Co.’s dividend payout ratio (DPR) is presently 46.43%.
Arthur J. Gallagher & Co. Company Profile (Free Report)
Arthur J. Gallagher & Co is a global insurance brokerage, risk management and consulting company. The company helps businesses, institutions and individuals identify, manage and transfer risk through insurance and related services.
Its operations include retail insurance brokerage, employee benefits consulting, risk management, claims administration, actuarial services, captive insurance and wholesale brokerage. Gallagher arranges commercial property and casualty coverage, personal insurance, specialty insurance and employee benefit programs, while also providing services designed to help clients manage workplace, liability and other operational risks.
Founded in 1927 by Arthur J.
Featured Stories Five stocks we like better than Arthur J. Gallagher & Co. Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Arthur J. Gallagher & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arthur J. Gallagher & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.0 billion in aggregate principal amount of senior notes due on September 15, 2034, which will bear interest at a rate of 6.250% per annum (the “notes”). The aggregate principal amount of notes to be issued in the offering was increased to $2.0 billion from the previously announced amount of $1.5 billion. Completi.
In the latest close session, AutoZone (AZO - Free Report) was down 1.06% at $2,951.61. This change lagged the S&P 500's daily loss of 0.58%. Elsewhere, the Dow saw a downswing of 1.18%, while the tech-heavy Nasdaq depreciated by 0.32%.
The auto parts retailer's stock has dropped by 2.76% in the past month, exceeding the Retail-Wholesale sector's loss of 5.84% and lagging the S&P 500's loss of 0.36%.
Market participants will be closely following the financial results of AutoZone in its upcoming release. The company plans to announce its earnings on September 22, 2026. The company's earnings per share (EPS) are projected to be $54.97, reflecting a 12.85% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $6.71 billion, indicating a 7.52% growth compared to the corresponding quarter of the prior year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $150.98 per share and revenue of $20.48 billion, indicating changes of +4.22% and +8.13%, respectively, compared to the previous year.
Investors should also note any recent changes to analyst estimates for AutoZone. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.08% downward. Currently, AutoZone is carrying a Zacks Rank of #4 (Sell).
In terms of valuation, AutoZone is currently trading at a Forward P/E ratio of 17. This represents a discount compared to its industry average Forward P/E of 17.43.
Also, we should mention that AZO has a PEG ratio of 1.49. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As of the close of trade yesterday, the Automotive - Retail and Wholesale - Parts industry held an average PEG ratio of 2.18.
The Automotive - Retail and Wholesale - Parts industry is part of the Retail-Wholesale sector. Currently, this industry holds a Zacks Industry Rank of 71, positioning it in the top 29% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Science Applications International (NASDAQ:SAIC – Get Free Report) and TriNet Group (NYSE:TNET – Get Free Report) are both mid-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk.
Institutional and Insider Ownership 76.0% of Science Applications International shares are owned by institutional investors. Comparatively, 96.8% of TriNet Group shares are owned by institutional investors. 0.7% of Science Applications International shares are owned by company insiders. Comparatively, 40.0% of TriNet Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability This table compares Science Applications International and TriNet Group’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Science Applications International 5.13% 34.68% 9.45% TriNet Group 3.58% 227.28% 6.04% Dividends Science Applications International pays an annual dividend of $1.48 per share and has a dividend yield of 1.2%. TriNet Group pays an annual dividend of $1.16 per share and has a dividend yield of 1.8%. Science Applications International pays out 17.3% of its earnings in the form of a dividend. TriNet Group pays out 31.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. TriNet Group has increased its dividend for 1 consecutive years. TriNet Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Risk & Volatility Science Applications International has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500. Comparatively, TriNet Group has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.
Earnings and Valuation This table compares Science Applications International and TriNet Group”s revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Science Applications International $7.26 billion 0.74 $358.00 million $8.55 14.92 TriNet Group $5.01 billion 0.60 $155.00 million $3.74 17.54 Science Applications International has higher revenue and earnings than TriNet Group. Science Applications International is trading at a lower price-to-earnings ratio than TriNet Group, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations This is a summary of recent ratings and recommmendations for Science Applications International and TriNet Group, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Science Applications International 1 8 2 0 2.09 TriNet Group 1 5 1 0 2.00 Science Applications International currently has a consensus price target of $125.22, suggesting a potential downside of 1.82%. TriNet Group has a consensus price target of $56.80, suggesting a potential downside of 13.43%. Given Science Applications International’s stronger consensus rating and higher possible upside, research analysts plainly believe Science Applications International is more favorable than TriNet Group.
Summary Science Applications International beats TriNet Group on 10 of the 17 factors compared between the two stocks.
(Get Free Report)
Science Applications International Corporation provides technical, engineering, and enterprise information technology (IT) services primarily in the United States. The company’s offerings include engineering; technology integration; IT modernization; maintenance of ground and maritime systems; logistics; training and simulation; operation and program support services; and end-to-end services, such as design, development, integration, deployment, management and operations, sustainment, and security of its customers’ IT infrastructure, as well as cloud migration, managed services, infrastructure modernization, and enterprise IT-as-a-service solutions. It serves the U.S. military comprising Army, Air Force, Navy, Marines, and Coast Guard; Department of Defense agencies; National Aeronautics and Space Administration; the U.S. Department of State; Department of Justice; Department of Homeland Security; and various intelligence community agencies, as well as U.S. federal civilian agencies. The company was formerly known as SAIC Gemini, Inc. and changed its name to Science Applications International Corporation in September 2013. Science Applications International Corporation was founded in 1969 and is headquartered in Reston, Virginia.
About TriNet Group (Get Free Report)
TriNet Group, Inc. provides comprehensive and flexible human capital management services for small and medium size businesses in the United States. The company offers multi-state payroll processing and tax administration; employee benefits programs, including health insurance and retirement plans; workers compensation insurance and claims management; employment and benefits law compliance; and other HR related services. It also provides technology platform, an online and mobile tool that allows users to store, view, and manager HR information and administer various HR transactions, such as payroll processing, tax administration and credits, employee onboarding and termination, employee performance, time and attendance, compensation reporting, expense management, and benefits enrollment and administration, as well as incorporated workforce analytics and allows professional employer organization clients to generate HR data, payroll, compensation, and other custom reports. The company serves clients in various industries, including technology, professional services, financial services, life sciences, and not-for-profit. It sells its solutions through its direct sales organization. TriNet Group, Inc. was incorporated in 1988 and is headquartered in Dublin, California.
Receive News & Ratings for Science Applications International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science Applications International and related companies with MarketBeat.com's FREE daily email newsletter.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Matador Resources (MTDR - Free Report) Headquartered in Dallas, TX, Matador Resources Company is an oil and natural gas company engaged in the exploration, development, production and acquisition of shale and other unconventional resources in the United States. Its upstream operations are focused primarily on the oil and liquids-rich portions of the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. The company also operates in the Haynesville shale and Cotton Valley plays in Northwest Louisiana.
MTDR is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Oils-Energy stock. MTDR has a Momentum Style Score of A, and shares are up 13.3% over the past four weeks.
Six analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.45 to $7.51 per share. MTDR boasts an average earnings surprise of +21.2%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, MTDR should be on investors' short list.
Primoris timeline disclosure events are alleged to show how project-cost problems progressed from earlier warning signs to a June 2026 guidance reset tied to six renewable energy projects.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SueWallSt notifies investors in Primoris Services Corporation (NYSE: PRIM) that a class action has been filed on behalf of shareholders who purchased securities between August 5, 2025 and June 22, 2026. See if you could be eligible to recover or call (888) SueWallSt.
PRIM fell $23.39 per share, or 21.6%, from $108.34 to $84.95 on June 23, 2026. The lead plaintiff deadline is September 21, 2026.
Primoris Timeline Disclosure Events Alleged in the Complaint
The securities action alleges that Primoris reassured investors about disciplined bidding, estimating processes, project execution, and risk management while significant fixed-price renewable energy projects were allegedly experiencing cost overruns, delays, and margin pressure.
The timeline begins with second-quarter 2025 results and continues through a sequence of 2026 disclosures. As claimed, the timeline shows how disclosures provided additional information about renewable energy project execution problems before the June 22, 2026 business update identified substantial challenges affecting six projects.
Timeline of Alleged Disclosure Failures
August 5, 2025: Primoris discussed second-quarter results and allegedly emphasized disciplined bidding, project execution, and risk management for its Energy segment.February 23, 2026: Primoris disclosed increased costs on certain renewable energy projects, challenging soil conditions, and margin compression, followed by an approximately 8% decline to $151.92 on February 24, 2026.May 5, 2026: Primoris reported revenue and margin pressure, delayed project starts, weaker first-quarter results, and a reduced full-year 2026 EPS outlook, followed by a decline to $101.23 on May 6, 2026.June 8, 2026: Primoris announced the immediate departure of its President of Renewables, and Guggenheim Securities reportedly questioned whether the Company had fully scoped ongoing solar project challenges.June 22, 2026: Primoris announced an internal review, supported by an independent third-party industry expert, identified substantial cost overruns, project delays, and execution challenges affecting six renewable energy projects. Why the Chronology Matters for PRIM Shareholders
The complaint contends that Primoris’ financial guidance depended on reliable cost-to-complete forecasting because the Company used a cost-to-cost input method for long-term contracts. The action alleges that deficiencies in estimating and project oversight caused expected project costs to be understated and margin deterioration to be recognized later than it should have been.
"Timely disclosure of material developments is fundamental to fair and efficient markets. The alleged sequence here is important because investors were receiving updated guidance while the complaint claims project-cost issues were still not fully reflected." -- Joseph E. Levi, Esq.
By June 22, 2026, Primoris had reduced 2026 Adjusted EPS guidance to $2.05 to $2.60 and Adjusted EBITDA guidance to $275 million to $325 million. The lawsuit alleges that the guidance reset represented the culmination of earlier disclosure failures involving renewable energy project costs and execution.
Calculate your potential recovery or call (888) SueWallSt.
WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the PRIM Lawsuit
Q: What is the PRIM class action lawsuit about? A: A securities class action has been filed against Primoris Services Corporation (NYSE: PRIM) alleging materially false and misleading statements between August 5, 2025 and June 22, 2026. Shares fell approximately 21.6% after the Company announced an internal review identifying substantial cost overruns, project delays, and execution challenges affecting six renewable energy projects.
Q: How much did PRIM stock drop? A: Shares fell approximately 21.6%, a decline of $23.39 per share, from $108.34 to $84.95 on June 23, 2026 after Primoris announced the internal review findings, slashed 2026 guidance, and announced the resignation of its Chief Operating Officer.
Q: What specific misstatements does the PRIM lawsuit allege? A: The complaint alleges Primoris made materially false or misleading statements regarding disciplined bidding, estimating processes, project controls, cost-to-complete forecasting, and its ability to manage risk on fixed-price renewable energy projects.
Q: What court was the PRIM class action filed in? A: The case was filed in the United States District Court for the Northern District of Texas, Dallas Division, and is governed by the Private Securities Litigation Reform Act of 1995.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What documents are useful for evaluating PRIM losses? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices are useful for evaluating potential losses.
Q: What if I already sold my PRIM shares, can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.
Q: What does it cost me to participate? A: There is no upfront cost for an initial evaluation. Securities class actions are generally handled on a pure contingency basis, and any attorneys' fees and expenses awarded to class counsel are subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 [email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Primoris Services Corporation ("Primoris" or the "Company") (NYSE: PRIM) on behalf of investors that purchased or otherwise acquired Primoris common stock between August 5, 2025 and June 22, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in Primoris and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than September 21, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
The complaint alleges that the Defendants misled investors by representing that the Company maintained "disciplined bidding," "well-developed estimating processes," effective project controls, and reliable cost forecasting that enabled it to accurately price and execute fixed-price renewable energy projects, "manage risk," and reliably forecast revenues, margins, and earnings.
The truth was allegedly revealed through a series of disclosures between February 23, 2026 and June 22, 2026, culminating in Primoris' announcement that an internal review, supported by an independent third-party industry expert, had identified significant cost overruns, project delays, and execution challenges affecting six renewable energy projects.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Primoris and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until September 21, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Primoris securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On February 23, 2026, Primoris issued a press release reporting its fourth-quarter and full-year 2025 financial results. In the press release, Primoris disclosed increased costs on certain renewable energy projects, more challenging-than-anticipated soil conditions, and margin compression within its Energy segment, acknowledging that these issues adversely affected fourth-quarter profitability despite higher revenue.
On this news, Primoris’s stock price fell $13.72 per share, or 8.28%, to close at $151.92 per share on February 24, 2026.
Then, on May 5, 2026, Primoris issued a press release reporting its financial results for the first quarter of 2026. In the press release, Primoris disclosed additional adverse developments affecting its renewable energy business, including revenue and margin pressure, delayed project starts, and weaker-than-expected first-quarter 2026 results. The Company also reduced its full-year 2026 Adjusted EPS guidance from $5.80-$6.00 to $4.80-$5.00 and lowered its Adjusted EBITDA guidance.
On this news, Primoris’s stock price fell $101.69 per share, or 50.11%, to close at $101.23 per share on May 6, 2026.
Then, on June 8, 2026, Primoris issued a press release announcing that Anthony Vorderbruggen, the Company’s President of Renewables, was departing Primoris, effective immediately.
On this news, Primoris’s stock price fell $18.92 per share, or 15.4%, to close at $103.90 per share on June 9, 2026.
Finally, on June 22, 2026, Primoris issued a Business Update announcing that, following an internal review supported by an independent third-party industry expert, it had identified substantial challenges, cost overruns, and project delays affecting six renewable energy projects. The Company reduced its full-year 2026 Adjusted EPS guidance to $2.05-$2.60, lowered its Adjusted EBITDA guidance to $275 million-$325 million, projected that 2026 Renewables revenue would decline to approximately $2.1 billion, and announced the resignation of its Chief Operating Officer.
On this news, Primoris’s stock price fell $23.39 per share, or 21.59%, to close at $84.95 per share on June 23, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM) investors of the September 21, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
[CONTACT THE FIRM IF YOU SUFFERED A LOSS]
What Is The Lawsuit About?
The lawsuit has been filed on behalf of investors who purchased securities during the period of August 5, 2025 and June 22, 2026, inclusive (“the Class Period”). The lawsuit alleges that Primoris made materially false and misleading statements regarding Primoris’ cost estimation, cost-to-complete forecasting, project execution, ability to manage project risk, financial performance, and financial guidance because the Company knew or recklessly disregarded that: (i) Primoris’ cost estimation, cost-to-complete forecasting, and project oversight processes were deficient and failed to provide reliable estimates of the costs and expected profitability of significant fixed-price renewable energy projects; (ii) as a result, Primoris systematically underestimated the costs and risks of significant fixed-price renewable energy projects that were experiencing material cost overruns, execution problems, and schedule delays; and (iii) accordingly, the Company’s statements regarding its estimating processes, project execution, ability to manage project risk, financial performance, and financial guidance lacked a reasonable basis and omitted material adverse facts.
On February 23, 2026, Primoris reported fourth quarter and full-year 2025 financial results, disclosing increased costs on certain renewable energy projects, more challenging-than-anticipated conditions, and margin compression within its Energy segment, acknowledging that these issues adversely affected profitability despite higher revenue. On this news, Primoris’ stock price fell $13.72 per share, or over 8%, to close at $151.92 per share on February 24, 2026.
Then, on May 5, 2026, the Company reported first quarter 2026 results, disclosed additional adverse developments affecting its renewable energy business, including revenue and margin pressure, delayed project starts, and weaker-than-expected first-quarter 2026 results. The Company also reduced its full-year 2026 Adjusted EPS guidance from $5.80-$6.00 to $4.80-$5.00 and lowered its Adjusted EBITDA guidance. On this news, Primoris’ stock price fell by $101.69, or over 50%, to close at $101.23 per share on May 6, 2026.
On June 8, 2026, Primoris announced that Anthony Vorderbruggen, the Company’s President of Renewables, was departing the Company, effective immediately. On this news, Primoris’ stock price declined approximately 15%, closing at $103.90 per share on June 9, 2026.
Finally, on June 22, 2026, Primoris announced that an internal review, supported by an independent third-party industry expert, had identified significant cost overruns, project delays, and execution challenges affecting six renewable energy projects. The Company also reduced its 2026 Adjusted EPS guidance to $2.05-$2.60 and lowered its Adjusted EBITDA guidance. Additionally, Primoris announced the resignation of Jeremy Kinch as Chief Operating Officer. On this news, Primoris’ stock price fell by $23.39 per share, or over 21%, to close at $84.95 on June 23, 2026.
[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]
What Should I Do?
If you purchased or otherwise acquired Primoris securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
What is the Lead Plaintiff Deadline?
Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.
[WHAT IS A SECURITIES CLASS ACTION?]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Primoris Services who were adversely affected if they purchased the Company’s shares between August 5, 2025 and June 22, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Texas.
Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nyse-prim/
Primoris investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3615 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-prim/ to learn more.
CLICK HERE for more information
CASE DETAILS: According to the Complaint, Primoris and certain of its executives are charged with failing to disclose material information during the class period, violating federal securities laws.
On June 22, 2026, following a series of prior negative disclosures, the Company disclosed that, following an internal review supported by an independent third-party industry expert, it had identified substantial challenges, cost overruns, and project delays affecting six renewable energy projects, and reduced its full-year 2026 Adjusted EPS guidance to $2.05-$2.60, lowered its Adjusted EBITDA guidance to $275 million-$325 million, projected that 2026 Renewables revenue would decline to approximately $2.1 billion, and announced the resignation of its Chief Operating Officer.
On this news, the price of Primoris shares fell 22%, closing at $84.95 per share on June 23, 2026.
The case is Boston Retirement System v. Primoris Services Corp., No. 26-cv-02416.
WHAT TO DO? If you invested in Primoris and suffered a loss during the relevant time frame, you have until September 21, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
To Learn More, Click HERE
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163
New York, New York--(Newsfile Corp. - September 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primoris Services Corporation (NYSE: PRIM) between August 5, 2025 and June 22, 2026, inclusive (the "Class Period"), of the important September 21, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Primoris common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Primoris class action, go to https://rosenlegal.com/cases/primoris-services-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 21, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Primoris' cost estimation, cost-to-complete forecasting, and project oversight processes were deficient and failed to provide reliable estimates of the costs and expected profitability of significant fixed-price renewable energy projects; (2) as a result, Primoris systematically underestimated the costs and risks of significant fixed-price renewable energy projects that were experiencing material cost overruns, execution problems, and schedule delays; and (3) accordingly, defendants' statements regarding Primoris' estimating processes, project execution, ability to manage project risk, financial performance, and financial guidance lacked a reasonable basis and omitted material adverse facts. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Primoris class action, go to https://rosenlegal.com/cases/primoris-services-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/313393
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
San Diego, California--(Newsfile Corp. - September 8, 2026) - Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Primoris Services Corporation (NYSE: PRIM) securities between August 5, 2025 and June 22, 2026 (the "Class Period").
The lawsuit alleges that Primoris made materially false or misleading statements regarding the Company's cost forecasting, project oversight, and expected profitability of certain renewable energy construction projects.
The deadline to seek appoint as lead counsel is September 21, 2026.
Listen to our podcast.
Why Was Primoris Sued?
The complaint alleges that Primoris misled investors regarding its ability to accurately estimate costs and manage risks associated with major fixed-price renewable energy projects.
Specifically, the lawsuit alleges that during the Class Period the Company:
maintained deficient cost estimation, cost-to-complete forecasting, and project oversight processes;systematically underestimated the costs and risks associated with several significant fixed-price renewable energy projects;failed to disclose material cost overruns, project execution issues, and schedule delays affecting those projects; andmade positive statements regarding its estimating practices, project execution, risk management, financial performance, and financial guidance that allegedly lacked a reasonable basis because they omitted material adverse information.The complaint alleges that investors purchased Primoris securities at artificially inflated prices because these risks were not adequately disclosed.
What Happened to PRIM Stock?
According to the complaint, the truth emerged through a series of disclosures between February 23, 2026 and June 22, 2026.
The final disclosure occurred on June 22, 2026, when Primoris announced that an internal review, supported by an independent third-party industry expert, had identified:
significant cost overruns;project delays;execution challenges affecting six renewable energy projects;a substantial reduction to the Company's 2026 financial guidance;lower revenue expectations for its Renewables segment; andthe resignation of Chief Operating Officer Jeremy Kinch.Following these disclosures, Primoris' stock price fell from $108.34 to $84.95 per share, a decline of approximately 21.6%.
Who May Be Eligible?
The lawsuit seeks to represent investors who purchased or otherwise acquired Primoris Services Corporation (NYSE: PRIM) securities during the applicable Class Period. If you purchased Primoris stock during this period and suffered investment losses, you may have rights under the federal securities laws.
What Is a Lead Plaintiff?
The lead plaintiff is the investor appointed by the court to represent the interests of the proposed class throughout the litigation. Investors do not have to serve as lead plaintiff to potentially share in any recovery if the lawsuit is successful. If you choose to take no action, you can remain an absent class member.
The deadline to seek appointment as lead plaintiff is September 21, 2026.
Does It Cost Anything to Participate?
No. Robbins LLP represents investors on a contingency fee basis.
Contact Robbins LLP
Investors seeking additional information about the Primoris securities class action may submit an inquiry through Robbins LLP's website, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
About Robbins LLP
A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.
"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.
To be notified if a class action against Primoris Service Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Facebook
LinkedIn
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/313542
Source: Robbins LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Hsbc Holdings PLC raised its holdings in shares of Casey’s General Stores, Inc. (NASDAQ:CASY – Free Report) by 573.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 61,287 shares of the company’s stock after acquiring an additional 52,186 shares during the quarter. Hsbc Holdings PLC owned approximately 0.17% of Casey’s General Stores worth $48,669,000 as of its most recent filing with the SEC.
A number of other hedge funds have also made changes to their positions in CASY. Geode Capital Management LLC boosted its holdings in shares of Casey’s General Stores by 7.4% in the 4th quarter. Geode Capital Management LLC now owns 760,438 shares of the company’s stock valued at $420,416,000 after buying an additional 52,250 shares in the last quarter. Daiichi Life Insurance Co. Ltd. acquired a new stake in Casey’s General Stores during the 2nd quarter worth $1,222,000. Burns J W & Co. Inc. NY raised its stake in Casey’s General Stores by 103.5% during the 1st quarter. Burns J W & Co. Inc. NY now owns 2,448 shares of the company’s stock worth $1,782,000 after acquiring an additional 1,245 shares in the last quarter. North Dakota State Investment Board purchased a new stake in Casey’s General Stores in the fourth quarter valued at $720,000. Finally, Teachers Retirement System of The State of Kentucky lifted its position in Casey’s General Stores by 52.0% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 17,079 shares of the company’s stock valued at $12,431,000 after acquiring an additional 5,846 shares during the last quarter. Hedge funds and other institutional investors own 85.63% of the company’s stock.
Analysts Set New Price Targets Several equities analysts have issued reports on CASY shares. Zacks Research lowered Casey’s General Stores from a “strong-buy” rating to a “hold” rating in a report on Friday, June 5th. Evercore reissued an “outperform” rating and issued a $990.00 target price on shares of Casey’s General Stores in a report on Friday, June 12th. BMO Capital Markets raised Casey’s General Stores from a “market perform” rating to an “outperform” rating and set a $950.00 target price for the company in a research report on Monday, June 29th. Stephens set a $975.00 target price on Casey’s General Stores and gave the company an “overweight” rating in a research report on Friday, June 12th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $913.00 price target on shares of Casey’s General Stores in a research note on Wednesday, July 29th. Fourteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Casey’s General Stores has an average rating of “Moderate Buy” and a consensus price target of $928.53.
View Our Latest Stock Analysis on CASY Insiders Place Their Bets In other news, CEO Darren Rebelez sold 19,000 shares of the business’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $801.46, for a total transaction of $15,227,740.00. Following the transaction, the chief executive officer directly owned 89,174 shares in the company, valued at $71,469,394.04. The trade was a 17.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Katrina Lindsey sold 2,000 shares of the business’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $800.00, for a total transaction of $1,600,000.00. Following the transaction, the insider owned 6,668 shares in the company, valued at approximately $5,334,400. This trade represents a 23.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 30,243 shares of company stock valued at $24,421,877. Corporate insiders own 0.67% of the company’s stock.
Casey’s General Stores Price Performance Shares of NASDAQ CASY opened at $756.09 on Tuesday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.01 and a quick ratio of 0.60. The stock has a fifty day moving average price of $826.62 and a 200 day moving average price of $786.29. Casey’s General Stores, Inc. has a 1-year low of $497.38 and a 1-year high of $927.85. The company has a market cap of $27.98 billion, a PE ratio of 39.46, a P/E/G ratio of 2.58 and a beta of 0.59.
Casey’s General Stores (NASDAQ:CASY – Get Free Report) last announced its quarterly earnings data on Tuesday, June 9th. The company reported $4.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.31 by $1.06. The company had revenue of $4.57 billion for the quarter, compared to analysts’ expectations of $4.33 billion. Casey’s General Stores had a net margin of 4.07% and a return on equity of 18.73%. Casey’s General Stores’s revenue was up 14.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.63 EPS. Sell-side analysts forecast that Casey’s General Stores, Inc. will post 21.13 EPS for the current year.
(Free Report)
Casey’s General Stores, Inc (NASDAQ: CASY) is a U.S.-based convenience store chain that operates retail fuel stations and food-focused convenience outlets. Founded in 1959 in Boone, Iowa, the company has grown from a single neighborhood store into a regional operator known for combining traditional convenience retailing—fuel, packaged goods and tobacco—with a larger emphasis on fresh and prepared foods.
The company’s stores typically offer gasoline and diesel alongside a range of grocery essentials, grab-and-go items and made-to-order foodservice.
Recommended Stories Five stocks we like better than Casey’s General Stores 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Casey's General Stores Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Casey's General Stores and related companies with MarketBeat.com's FREE daily email newsletter.
ANKENY, Iowa--(BUSINESS WIRE)--Casey's General Stores, Inc. ("Casey's" or the "Company") (Nasdaq: CASY) one of the leading convenience store chains in the United States, today announced financial results for the three months ended July 31, 2026. First Quarter Key Highlights Diluted EPS of $7.37 up 27.7% from the same period a year ago. Net income was $273.7 million, up 27.1% from the prior year, and EBITDA1 was $485.1 million, up 17.1%, from the same period a year ago. Inside same-store sales i.
Caseys General Stores Inc (NASDAQ:CASY) shares are moving lower in extended trading Tuesday on the heels of the company’s first-quarter results.
Casey’s General Stores shares are retreating from recent levels. What’s behind CASY decline? Casey’s Q1 Highlights Q1 Revenue: $5.68 billion, versus estimates of $5.57 billion Q1 EPS: $7.37, versus estimates of $6.72 Inside same-store sales were up 3.2% year-over-year in the first quarter, down from 4.3% growth in the comparable quarter last year. Fuel same-store gallons sold were down 0.3% on a year-over-year basis.
“Guests are responding well to our compelling value proposition on our high-quality prepared food, especially in whole pies. On the fuel side, our team’s robust capabilities helped us navigate a volatile environment and produced strong results,” said Darren Rebelez, chairman, president and CEO of Casey’s.
Casey’s repurchased approximately $45.6 million of its common stock during the quarter. The company exited the period with approximately $1.4 billion in available liquidity, including approximately $524 million in cash and cash equivalents and approximately $857 million in available borrowing capacity on existing lines of credit.
Casey’s expects inside same-store sales to increase between 2% and 5% in fiscal 2027. The company expects same-store fuel gallons sold to be approximately flat, plus or minus 1%. Casey’s said it plans to open at least 120 stores in fiscal 2027 through a combination of M&A and new store construction.
CASY Shares Fall After HoursCASY Price Action: Casey’s shares were down 9.69% in after-hours, trading at $662.40 at the time of publication on Tuesday, according to Benzinga Pro.
Read Next
Image: Shutterstock.com
Market News and Data brought to you by Benzinga APIs
Casey's General Stores (CASY - Free Report) came out with quarterly earnings of $7.37 per share, beating the Zacks Consensus Estimate of $6.6 per share. This compares to earnings of $5.77 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +11.67%. A quarter ago, it was expected that this convenience store chain would post earnings of $3.36 per share when it actually produced earnings of $4.37, delivering a surprise of +30.06%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Casey's, which belongs to the Zacks Retail - Convenience Stores industry, posted revenues of $5.68 billion for the quarter ended July 2026, surpassing the Zacks Consensus Estimate by 0.43%. This compares to year-ago revenues of $4.57 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Casey's shares have added about 36.8% since the beginning of the year versus the S&P 500's gain of 12.8%.
What's Next for Casey's?While Casey's has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Casey's was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $6.29 on $5.36 billion in revenues for the coming quarter and $21.13 on $20.38 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Retail - Convenience Stores is currently in the top 42% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Darden Restaurants (DRI - Free Report) , another stock in the broader Zacks Retail-Wholesale sector, has yet to report results for the quarter ended August 2026. The results are expected to be released on September 24.
This owner of Olive Garden and other chain restaurants is expected to post quarterly earnings of $2.05 per share in its upcoming report, which represents a year-over-year change of +4.1%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Darden Restaurants' revenues are expected to be $3.2 billion, up 5.2% from the year-ago quarter.
Casey's General Stores (CASY - Free Report) reported $5.68 billion in revenue for the quarter ended July 2026, representing a year-over-year increase of 24.3%. EPS of $7.37 for the same period compares to $5.77 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $5.65 billion, representing a surprise of +0.43%. The company delivered an EPS surprise of +11.67%, with the consensus EPS estimate being $6.60.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Casey's performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Same-store sales - Grocery & General Merchandise - YoY change: 2.7% versus the three-analyst average estimate of 3.6%.Inside same-store sales: 3.2% versus 3.8% estimated by three analysts on average.Number of Stores (EOP): 2,959 versus the three-analyst average estimate of 2,968.Number of Fuel gallons sold: 934.21 million compared to the 939.9 million average estimate based on three analysts.Same-store sales - Prepared Food & Dispensed Beverage - YoY change: 4.8% compared to the 4.3% average estimate based on three analysts.Same-store sales - Fuel gallons - YoY change: -0.3% compared to the 0.3% average estimate based on three analysts.Number of Stores (BOP): 2,944 compared to the 2,944 average estimate based on two analysts.Net Sales- Fuel: $3.72 billion compared to the $3.87 billion average estimate based on three analysts. The reported number represents a change of +36.3% year over year.Net Sales- Other: $176 million versus the three-analyst average estimate of $156.25 million. The reported number represents a year-over-year change of +17.6%.Net Sales- Prepared Food & Dispensed Beverage: $492.58 million compared to the $487.93 million average estimate based on three analysts. The reported number represents a change of +7.5% year over year.Net Sales- Grocery & General Merchandise: $1.28 billion compared to the $1.3 billion average estimate based on three analysts. The reported number represents a change of +4.9% year over year.Gross Profit- Grocery & General Merchandise: $457.84 million versus $468.56 million estimated by three analysts on average.View all Key Company Metrics for Casey's here>>>
Shares of Casey's have returned -11.5% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Casey's General Stores delivered solid Q1 results, but valuation remains only fair after a post-earnings decline. CASY's operational performance is healthy, with 24% revenue and 27% EPS growth, but store expansion and SSS are tracking toward the low/mid guidance range. Despite improved margins and compounding potential, the company trades at a premium multiple, offering limited upside at current levels.
Key Takeaways AMN expects Q3 Nurse and Allied Solutions revenues to rise 9-11% as staffing demand strengthens.MSP arrangements generated about 46% of AMN Healthcare's consolidated revenues in Q2'26.AMN is expanding AI-enabled language, leadership and workforce tools to diversify beyond staffing. AMN Healthcare Services, Inc. (AMN - Free Report) is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), favorable healthcare staffing demand, diversified workforce solutions, and investments in technology and AI-driven platforms. However, stiff competition, industry regulations and changing marketplace conditions are major downsides.
Shares of this Zacks Rank #3 (Hold) company have skyrocketed 114.5% year to date against the industry's 12% decline. However, the S&P 500 Index has risen 12.2% in the said timeframe.
This renowned player in the healthcare total talent services space has a market capitalization of $1.31 billion. The company projects 144.1% year-over-year earnings growth for 2026 and expects to witness continued improvements in its business. AMN Healthcare surpassed the Zacks Consensus Estimate in the trailing four quarters, delivering an average earnings surprise of 96.63%.
Image Source: Zacks Investment Research
Factors Favoring AMN StockFavorable Healthcare Staffing Demand: Demand for healthcare staffing remains supported by population growth, aging demographics, increasing care complexity and persistent labor shortages. Healthcare providers are increasingly using flexible workforce models and external staffing partners to manage labor variability and improve efficiency.
In second-quarter 2026, travel nurse volume increased 6% year over year, while allied volume rose 7%, the strongest growth rates in four years. Travel nurse orders turned positive in May and reached approximately 40% growth by early August, while allied orders grew in the mid-teens during June and July. Management expects more than 10% year-over-year growth in both businesses in the third quarter and forecasts Nurse and Allied Solutions revenue growth of 9-11%. Sustained demand could drive stronger staffing volumes and support AMN’s revenue recovery.
Expanding MSP Penetration: AMN Healthcare’s Managed Services Programs (MSPs) strengthen client relationships by helping providers manage supplemental labor across AMN and third-party suppliers. MSP arrangements accounted for approximately 46% of consolidated revenues in second-quarter 2026. In 2025, AMN managed $1.8 billion of spend through MSPs and $3.3 billion, including vendor-neutral programs. Broad-based demand across regions, provider sizes and service models further supports the platform’s workforce optimization capabilities. The scale of AMN’s MSP platform provides recurring access to large healthcare staffing demand and strengthens client retention while creating opportunities to capture additional market share.
Diversified Workforce Solutions: AMN has expanded beyond traditional staffing into technology-enabled total talent solutions spanning staffing, recruitment, MSP, Vendor Management Systems (VMS), language services, consulting and workforce optimization. Second-quarter growth included travel nurse, allied and international nurse staffing, while physician search increased new searches 40% year over year and executive search rose 30%.
AMN also expanded its WorkWise platform with supplier and rate intelligence, while Passport users surpassed 400,000. In June 2026, the company acquired Jaide Health to enhance AI-enabled language interpretation and ESSENTIAL Leadership Assessment to expand leadership evaluation, coaching and succession planning capabilities. This broad service portfolio creates multiple avenues for growth beyond traditional healthcare staffing.
Downsides of AMN StockStiff Competition: AMN Healthcare operates in a highly competitive staffing and workforce-solutions market, with pressure from national, regional and specialized providers. Locum tenens demand is increasingly shifting toward vendor-neutral channels, which management describes as highly competitive. Language services revenues also declined as pricing per minute fell 8%, while Technology and Workforce Solutions revenues dropped 15% year over year. Continued competition could limit pricing power, fill rates and revenue growth.
Changing Marketplace Conditions: Healthcare providers continue to adjust staffing models and focus on controlling labor costs. Contingent labor premiums have fallen to the mid- to high-single digits from the mid- to high-teens before COVID-19, indicating a normalization of pandemic-era economics. Although Nurse and Allied demand is recovering, third-quarter 2026 consolidated revenue guidance calls for only 1-3% year-over-year growth as declines in other segments offset staffing gains. These market shifts could slow AMN’s overall recovery.
Healthcare Industry Regulations: Regulatory and administrative changes can affect clinician availability, client demand and international staffing. AMN’s international nurse business benefited from forward movement in visa cutoff dates, but embassy appointment backlogs remain a constraint. Management indicated that resolving these delays will influence international growth in 2027. Changes in immigration policies or continued processing delays could therefore create staffing shortages, delay placements and increase operating uncertainty.
Estimate TrendAMN Healthcare has been witnessing a positive estimate revision trend for 2026. Over the past 60 days, the Zacks Consensus Estimate for its earnings per share has improved 22.9% to $3.32.
The Zacks Consensus Estimate for third-quarter 2026 revenues and earnings per share is pegged at $648 million and 22 cents, respectively, suggesting 2.1% growth and a 43.6% decline from the year-ago reported numbers.
Key PicksSome better-ranked stocks from the broader medical space are Veracyte (VCYT - Free Report) , Globus Medical (GMED - Free Report) and West Pharmaceutical (WST - Free Report) .
Veracyte, currently flaunting a Zacks Rank #1 (Strong Buy), reported a second-quarter 2026 adjusted earnings per share (EPS) of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
You can see the complete list of today’s Zacks #1 Rank stocks here.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in the trailing four quarters, the average surprise being 41.8%.
Globus Medical, currently carrying a Zacks Rank #2 (Buy), reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in the trailing four quarters, the average surprise being 27.9%.
West Pharmaceutical, carrying a Zacks Rank #2 at present, reported second-quarter 2026 adjusted EPS of $2.37, which beat the Zacks Consensus Estimate by 13.9%. Revenues of $872.3 million surpassed the Zacks Consensus Estimate by 4.2%.
WST has an estimated long-term earnings growth rate of 16%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 17.4%.
, /PRNewswire/ -- ONE Gas, Inc. (NYSE: OGS) today announced it will participate in the American Gas Association Mini-Forum, September 15, 2026, in Boston.
Christopher Sighinolfi, senior vice president and chief financial officer, and Mark Smith, vice president and treasurer, will be conducting a series of meetings with members of the investment community.
The materials utilized at the conference will be accessible on the ONE Gas website, www.onegas.com/investors/events-and-presentations.
ONE Gas, Inc. (NYSE: OGS) is a 100-percent regulated natural gas utility, and trades on the New York Stock Exchange and the NYSE Texas under the symbol "OGS." ONE Gas is included in the S&P MidCap 400 Index and is one of the largest natural gas utilities in the United States.
Headquartered in Tulsa, Oklahoma, ONE Gas provides a reliable and affordable energy choice to more than 2.3 million customers in Kansas, Oklahoma and Texas. Its divisions include Kansas Gas Service, the largest natural gas distributor in Kansas; Oklahoma Natural Gas, the largest in Oklahoma; and Texas Gas Service, the third largest in Texas, in terms of customers.
For more information and the latest news about ONE Gas, visit onegas.com and follow its social channels: @ONEGas, Facebook, Linkedln and YouTube.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Strategic Education (STRA - Free Report) Strategic Education or SEI, is an education services company that provides campus-based and online post-secondary education, along with programs designed to build job-ready skills for high-demand markets. Its higher education institutions are Capella University and Strayer University in the United States and Torrens University in Australia. The company primarily serves working adult students.
STRA is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Consumer Discretionary stock. STRA has a Momentum Style Score of B, and shares are up 0.2% over the past four weeks.
For fiscal 2026, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.03 to $7.23 per share. STRA boasts an average earnings surprise of +9%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, STRA should be on investors' short list.
In the latest trading session, Oneok Inc. (OKE - Free Report) closed at $97.51, marking a +2.18% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.58%. Meanwhile, the Dow lost 1.18%, and the Nasdaq, a tech-heavy index, lost 0.32%.
The stock of natural gas company has risen by 5.63% in the past month, lagging the Oils-Energy sector's gain of 6.77% and overreaching the S&P 500's loss of 0.36%.
Analysts and investors alike will be keeping a close eye on the performance of Oneok Inc. in its upcoming earnings disclosure. The company is predicted to post an EPS of $1.49, indicating constancy compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $11.77 billion, indicating a 36.34% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of $5.75 per share and a revenue of $43.77 billion, demonstrating changes of +6.09% and +30.16%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oneok Inc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.47% lower within the past month. Oneok Inc. currently has a Zacks Rank of #3 (Hold).
Digging into valuation, Oneok Inc. currently has a Forward P/E ratio of 16.59. This expresses a premium compared to the average Forward P/E of 14.59 of its industry.
Meanwhile, OKE's PEG ratio is currently 2.7. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. OKE's industry had an average PEG ratio of 2.06 as of yesterday's close.
The Oil and Gas - Production Pipeline - MLB industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 51, which puts it in the top 21% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Shares of Green Thumb Industries Inc. (GTBIF - Free Report) have gained 10.1% over the past four weeks to close the last trading session at $7.68, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15.61 indicates a potential upside of 103.3%.
The average comprises seven short-term price targets ranging from a low of $10.00 to a high of $18.38, with a standard deviation of $2.94. While the lowest estimate indicates an increase of 30.2% from the current price level, the most optimistic estimate points to a 139.3% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.
While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.
But, for GTBIF, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.
Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.
While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?
They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.
However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.
That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.
Here's Why There Could be Plenty of Upside Left in GTBIFAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Over the last 30 days, the Zacks Consensus Estimate for the current year has increased 5.3%, as one estimate has moved higher compared to no negative revision.
Moreover, GTBIF currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Therefore, while the consensus price target may not be a reliable indicator of how much GTBIF could gain, the direction of price movement it implies does appear to be a good guide.
QuoteMedia (OTCMKTS:QMCI – Get Free Report) and Getty Images (NYSE:GETY – Get Free Report) are both small-cap communication services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership.
Valuation & Earnings This table compares QuoteMedia and Getty Images”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QuoteMedia $20.25 million 0.69 -$2.32 million ($0.02) -7.75 Getty Images $981.29 million 0.11 -$206.12 million ($0.39) -0.66 QuoteMedia has higher earnings, but lower revenue than Getty Images. QuoteMedia is trading at a lower price-to-earnings ratio than Getty Images, indicating that it is currently the more affordable of the two stocks. Analyst Recommendations This is a summary of current recommendations and price targets for QuoteMedia and Getty Images, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QuoteMedia 0 1 0 0 2.00 Getty Images 1 3 1 0 2.00 Getty Images has a consensus target price of $3.92, suggesting a potential upside of 1,427.24%. Given Getty Images’ higher possible upside, analysts plainly believe Getty Images is more favorable than QuoteMedia.
Insider and Institutional Ownership 45.8% of Getty Images shares are held by institutional investors. 47.1% of QuoteMedia shares are held by company insiders. Comparatively, 9.3% of Getty Images shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability This table compares QuoteMedia and Getty Images’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets QuoteMedia -9.06% N/A -34.83% Getty Images -16.24% -26.82% -5.25% About QuoteMedia (Get Free Report)
QuoteMedia, Inc. provides financial data, market research information, analytics, news feeds, and financial software solutions to online brokerages, banks, clearing firms, financial service companies, media portals, and public corporations worldwide. It collects, aggregates, and delivers delayed and real-time financial data content through the Internet. The company also offers market information and services, including streaming stock market data feeds, research and analysis information, content applications, portfolio management systems, software products, corporate investor relations provisioning, news services, mobile apps, and custom development. In addition, its data feeds coverage includes equities, options, futures, commodities, currencies, mutual funds, ETFs, and indices. Further, the company provides financial data delivery application products and components comprising quote modules, charts, market movers, news, watch lists, tickers, market summaries, option chains, filings, fundamentals, investor relations solutions, stock and fund screeners, and others; and QMod, a web delivery system for delivering market data content to Web platforms. Additionally, it offers portfolio managements systems, including Quotestream Desktop, We, and Mobile, a Web-delivered, embedded application providing real-time, tick-by-tick, streaming market quotes and research information; Quotestream Professional that offers low-latency tick-by-tick data, customizable screens, advanced charting, comprehensive technical analysis, news, and research data for financial services professionals; Web Portfolio Manager, which provides immediate web access to detailed quote data, market and company news, charting, depth/level II, filings, historical data, snap quotes, and others; and Quotestream Connect that delivers real time data feeds to individual users to power third party applications. The company was incorporated in 1992 and is headquartered in Fountain Hills, Arizona.
About Getty Images (Get Free Report)
Getty Images Holdings, Inc. offers creative and editorial visual content solutions in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Its products include Getty Images that offers creative and editorial content including stills, music and video which focuses on corporate, agency, and media customers; iStock.com, an e-commerce offering where customers have access to creative stills and video; Unsplash.com, a platform offering free stock photo downloads and paid subscriptions targeted to the high-growth prosumer and semi-professional creator segments; and Unsplash+ that provides access to unique model released content with expanded legal protections. In addition, it maintains privately-owned photographic archives covering news, sport, and entertainment, as well as variety of subjects, including lifestyle, business, science, health, wellness, beauty, sports, transportation, and travel. Further, the company provides music licensing, and digital asset management and distribution services. It serves media outlets, advertising agencies and corporations, individual creators, and prosumers. The company was formerly known as Getty Images, Inc. Getty Images Holdings, Inc. was founded in 1995 and is headquartered in Seattle, Washington.
Receive News & Ratings for QuoteMedia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuoteMedia and related companies with MarketBeat.com's FREE daily email newsletter.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether OSI and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On August 20, 2026, OSI reported fiscal fourth-quarter and full-year 2026 financial results, including revenue that fell short of consensus expectations. OSI attributed the revenue miss to deferred product deliveries stemming from site constraints.
On this news, OSI’s stock price fell $11.36 per share, or 5.21%, to close at $206.73 per share on August 21, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK--(BUSINESS WIRE)---- $OSIS #ClassActionLawsuit--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On August 20, 2026, OSI reported its fourth quarter 2026 and full-year 2026 financial results, revealing fourth q.
OSIS SHAREHOLDER ALERT: OSI Systems, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What Happened?
On August 20, 2026, OSI reported its fourth quarter 2026 and full-year 2026 financial results, revealing fourth quarter revenue that fell short of analysts’ expectations by 8.5%, with sales falling 4.1% year-on-year to $484.1 million. The Company attributed the revenue shortfall to Security division delivery disruptions caused by conflicts in the Middle East, stating, “these results were affected by the timing of approximately $50 million of planned Security deliveries that moved beyond our June 30th fiscal year-end because of conflict-related delays and site access constraints in the Middle East.” On this news, OSI’s stock price fell $11.36, or 5.21%, to close at $206.73 per share on August 21, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.
If you purchased or otherwise acquired OSI securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908654634/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Second Rare Pediatric Disease (RPD) Designation for QRX003FDA Previously Granted RPD Designation for QRX003 in Netherton SyndromeIf a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin May Receive a Freely Tradable Priority Review Voucher (PRV)Quoin Expects to Initiate Phase 2 Study in 2H 2026; Study Plans to Enroll up to 12 Pediatric and Adult Peeling Skin Patients in the U.S. and EuropeThere are Currently No Approved Treatments for Peeling Skin Syndrome ASHBURN, Va., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the Company’s lead asset, QRX003, for the treatment of Peeling Skin Syndrome (PSS).
The designation reinforces the potential of QRX003 as a therapeutic candidate for a profoundly underserved pediatric population. This is the second RPD designation granted for QRX003, following the previously granted RPD designation for Netherton Syndrome.
The FDA’s Rare Pediatric Disease Designation program is intended to encourage the development of new therapies for serious and life-threatening diseases that primarily affect individuals under 18 years of age. If a New Drug Application (NDA) for QRX003 is approved, Quoin may qualify to receive a Priority Review Voucher (PRV), which can be redeemed to receive priority review for another marketing application or may be sold or transferred.
“We are very pleased to announce the receipt of Rare Pediatric Disease Designation for QRX003 for Peeling Skin Syndrome,” said Dr. Michael Myers, Chief Executive Officer of Quoin Pharmaceuticals. “With the IND cleared by FDA, the Quoin team is preparing to initiate the Phase 2 clinical study before the end of this year with plans to enroll up to 12 pediatric and adult Peeling Skin patients in the U.S. and Europe. This will be the first formal study ever conducted in the U.S. for this disease under an open IND.”
About Peeling Skin Syndrome (PSS)
Generalized inflammatory peeling skin syndrome (PSS) is a rare autosomal recessive genodermatosis caused by loss-of-function disease-causing variants of the corneodesmosin gene (CDSN), resulting in excessive shedding of the superficial layers of the epidermis. Patients generally suffer from a variety of conditions including severe pain and chronic pruritus (itch). There is currently no approved treatment for PSS.
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities, and care teams. Quoin's innovative pipeline is focused on two key platform products, QRX003 and QRX009, that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Pachyonychia Congenita, Gorlin Syndrome and Tuberous Sclerosis Complex, Microcystic Lymphatic Malformations, Venous Malformations, Angiofibromas and others. For more information, visit: www.quoinpharma.com or LinkedIn for updates.
Cautionary Note Regarding Forward Looking Statements
The Company cautions that statements in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as “expect,” “intend,” “plan,” “anticipate,” “believe,” “look forward to,” and “will,” among others. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to: the potential of QRX003 as a therapeutic candidate for Peeling Skin Syndrome and a profoundly underserved pediatric population, Quoin’s eligibility to receive Priority Review Vouchers upon approval of a New Drug Application for QRX003; the initiation of a Phase 2 clinical study for Peeling Skin Syndrome before the end of 2026 with plans to enroll up to 12 pediatric and adult patients in the U.S. and Europe; and Quoin’s belief that its products in development collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Pachyonychia Congenita, Gorlin Syndrome and Tuberous Sclerosis Complex, Microcystic Lymphatic Malformations, Venous Malformations, Angiofibromas and others. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company’s ability to pursue its regulatory strategy; the Company’s ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements; the Company’s ability to complete clinical trials on time and achieve desired results and benefits as expected; and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.
For further information, contact:
Quoin Pharmaceuticals Ltd.
Michael Myers, Ph.D., CEO [email protected]
Investor Relations
PCG Advisory
Jeff Ramson [email protected]
(646) 863-6341
Hsbc Holdings PLC lifted its position in shares of Tetra Tech, Inc. (NASDAQ:TTEK – Free Report) by 45.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 628,625 shares of the industrial products company’s stock after purchasing an additional 197,653 shares during the quarter. Hsbc Holdings PLC owned approximately 0.25% of Tetra Tech worth $17,955,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank bought a new position in Tetra Tech in the fourth quarter worth $115,162,000. Energy Income Partners LLC bought a new position in shares of Tetra Tech during the 2nd quarter worth about $68,512,000. AQR Capital Management LLC lifted its holdings in shares of Tetra Tech by 351.6% during the 4th quarter. AQR Capital Management LLC now owns 2,875,372 shares of the industrial products company’s stock worth $96,440,000 after acquiring an additional 2,238,721 shares during the period. Bank of America Corp DE acquired a new stake in shares of Tetra Tech during the 2nd quarter valued at about $57,135,000. Finally, Capital International Investors increased its stake in Tetra Tech by 27.4% in the fourth quarter. Capital International Investors now owns 9,016,577 shares of the industrial products company’s stock valued at $302,416,000 after acquiring an additional 1,936,902 shares during the period. 93.89% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets Several research analysts recently issued reports on TTEK shares. National Bank Financial dropped their price target on shares of Tetra Tech from $38.00 to $35.00 and set an “outperform” rating for the company in a research report on Monday, July 13th. Wall Street Zen lowered Tetra Tech from a “buy” rating to a “hold” rating in a research note on Saturday, August 22nd. Royal Bank Of Canada dropped their target price on Tetra Tech from $48.00 to $43.00 and set an “outperform” rating for the company in a report on Wednesday, July 22nd. Weiss Ratings upgraded Tetra Tech from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. Finally, Robert W. Baird set a $37.00 price target on Tetra Tech in a research report on Thursday, July 30th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $38.25.
Check Out Our Latest Stock Report on TTEK Tetra Tech Trading Down 0.8% Shares of NASDAQ TTEK opened at $35.64 on Wednesday. Tetra Tech, Inc. has a 1-year low of $25.81 and a 1-year high of $43.14. The company has a 50-day moving average of $33.79 and a two-hundred day moving average of $31.64. The company has a market cap of $9.13 billion, a PE ratio of 21.47 and a beta of 0.90. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.43.
Tetra Tech (NASDAQ:TTEK – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.40 by $0.02. The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.08 billion. Tetra Tech had a net margin of 8.60% and a return on equity of 22.32%. Tetra Tech’s revenue was down 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.43 earnings per share. Tetra Tech has set its Q4 2026 guidance at 0.450-0.480 EPS and its FY 2026 guidance at 1.560-1.590 EPS. As a group, equities analysts expect that Tetra Tech, Inc. will post 1.58 earnings per share for the current fiscal year.
Tetra Tech Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Thursday, August 27th. Stockholders of record on Thursday, August 13th were paid a $0.072 dividend. This represents a $0.29 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Thursday, August 13th. Tetra Tech’s dividend payout ratio (DPR) is 17.47%.
About Tetra Tech (Free Report)
Tetra Tech, Inc is a leading provider of consulting and engineering services with a focus on water, environment, infrastructure, resource management and energy sectors. Headquartered in Pasadena, California, the company delivers end-to-end solutions that encompass planning, design, engineering, program management and construction management. Tetra Tech’s multidisciplinary teams integrate science, technology and advisory services to address complex challenges in areas such as water resources, environmental remediation, sustainable infrastructure and renewable energy.
The company’s core offerings include environmental assessments and cleanup, water treatment and reuse, coastal and marine engineering, climate resilience planning, and engineering design for transportation and built environments.
Featured Stories Five stocks we like better than Tetra Tech Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding TTEK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tetra Tech, Inc. (NASDAQ:TTEK – Free Report).
Receive News & Ratings for Tetra Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tetra Tech and related companies with MarketBeat.com's FREE daily email newsletter.